AIMP1 and neoplasm: Cohorts of WT and AIMp1−/− mice were inoculated subcutaneously (s.c.)with 200,000 tumor cells and subsequently vaccinated with BMDC loaded with recombinant OVA protein and its immunodominant MHC class I peptide epitope SIINFEKL (Figure 1B).